Scarica l'app Stockscreener
1.69
0.60%
0.01
Dopo l'orario di chiusura:
1.61
-0.08
-4.73%
Quince Therapeutics Inc Borsa (QNCX) Ultime notizie
Custom strategy builders for tracking Quince Therapeutics Inc.Earnings Overview Summary & Stock Portfolio Risk Management - Newser
Historical volatility pattern of Quince Therapeutics Inc. visualizedPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - Newser
Quince Therapeutics Inc. stock chart pattern explainedMarket Movement Recap & Consistent Profit Trading Strategies - Newser
Is Quince Therapeutics Inc. stock bottoming outWeekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
Analyzing recovery setups for Quince Therapeutics Inc. investors2025 Geopolitical Influence & Low Risk High Reward Ideas - Newser
What institutional flow reveals about Quince Therapeutics Inc.Chart Signals & AI Enhanced Trading Signals - Newser
Using RSI to spot recovery in Quince Therapeutics Inc.Portfolio Risk Report & Weekly Chart Analysis and Trade Guides - Newser
What Fibonacci levels say about Quince Therapeutics Inc. reboundCPI Data & Community Consensus Stock Picks - Newser
Is it time to cut losses on Quince Therapeutics Inc.July 2025 Sector Moves & Verified Short-Term Plans - Newser
Quince Therapeutics Reports Q2 2025 Financial Results - MSN
Exit strategy if you’re trapped in Quince Therapeutics Inc.Market Activity Recap & Risk Controlled Stock Pick Alerts - Newser
Quince, Niagen, Intrabio busy in rare A-T disease - BioWorld MedTech
Quince Therapeutics (NASDAQ:QNCX) Price Target Lowered to $8.00 at JMP Securities - Defense World
Is Quince Therapeutics Inc. stock poised for growthWeekly Trading Summary & Weekly Setup with ROI Potential - Newser
How Quince Therapeutics Inc. stock performs during market volatilityEarnings Risk Report & Verified Swing Trading Watchlists - Newser
Quince Therapeutics Inc. Stock Lags Behind Sector BenchmarksBreakout Entry Signal Confirmation Tool Used - 선데이타임즈
Quince Therapeutics stock price target lowered to $8 by Citizens JMP - Investing.com South Africa
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - BioSpace
What makes Quince Therapeutics Inc. stock price move sharplyEarnings Based Stock Performance Forecast - Newser
Should you hold or exit Quince Therapeutics Inc. nowFree Growth Based Investment Plan Guidance - Newser
Published on: 2025-08-11 03:02:40 - Newser
New Product Launches: Will They Boost Quince Therapeutics Inc. Stock in 2025Fast Movement Forecast for Trading Success - Newser
Quince Therapeutics Inc. stock prediction for this weekFree Accurate Technical Trend Reversal Picks - Newser
Quince Therapeutics (QNCX) Projected to Post Earnings on Tuesday - Defense World
Can trapped investors hope for a rebound in Quince Therapeutics Inc.Market Downturn Defense Strategy Analysis - Newser
Using data tools to time your Quince Therapeutics Inc. exitFree Stock Market Entry Timing Signals - Newser
Citizens Jmp Initiates Coverage on Quince Therapeutics (NASDAQ:QNCX) - Defense World
Quince Therapeutics (NASDAQ:QNCX) Research Coverage Started at Citizens Jmp - Defense World
Quince Therapeutics and the Strategic Partnership with Option Care Health: A Pathway to eDSP Commercialization and Market Expansion - AInvest
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP - The Globe and Mail
Is Quince Therapeutics Inc. a candidate for recovery playTrend Following Ideas with Volume Confirmation - Newser
Quince Therapeutics (NASDAQ:QNCX) Coverage Initiated by Analysts at JMP Securities - Defense World
Analyst Upgrades and Initiations for Tuesday: Lionsgate Studios, MBX Biosciences, D-Wave Quantum, APA Corporation, and Quince Therapeutics - AInvest
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):